To our valued customers: Be advised that we have closed our Holland’s Drug location on South Locust Avenue. Please contact one of our other two locations for assistance with your prescription information. We look forward to continuing to serve you. Thank you!
Experimental Drug Shows Promise in Slowing Disability from Multiple Sclerosis
Results of a phase 3 clinical trial show an experimental drug called tolebrutinib can delay disability in patients with non-relapsing secondary progressive multiple sclerosis.
Health News is provided as a service to Holland's Drug site users by HealthDay. Holland's Drug nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.